Chronic Obstructive Pulmonary Disease as a Predictor of Cardiovascular Risk: A Case-Control Study

References

• Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436–1442. doi:10.1016/S0140-6736(96)07495-8.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805.
   PubMed Web of Science ®Google Scholar
• Stone IS, Barnes NC, Petersen SE. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 2012;98(14):1055–1062. doi:10.1136/heartjnl-2012-301759.
   PubMed Web of Science ®Google Scholar
• Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med. 1996;335(3):172–178. doi:10.1056/NEJM199607183350306.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Hansel NN, Sobradillo P, et al. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open. 2012;2(6):e002152. doi:10.1136/bmjopen-2012-002152.
   PubMed Web of Science ®Google Scholar
• Hole DJ, Watt GC, Davey Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313(7059):711–715. Discussion 715–6. doi:10.1136/bmj.313.7059.711.
   PubMed Web of Science ®Google Scholar
• Collins GS, Altman DG. Predicting the 10-year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 2012;344:e4181. doi:10.1136/bmj.e4181.
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi:10.1016/S0195-668X(03)00114-3.
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;2014:2889–2934.
   Google Scholar
• Khanji MY, Bicalho VVS, van Waardhuizen CN, et al. Cardiovascular risk assessment: a systematic review of guidelines. Ann Intern Med. 2016;165(10):713–722. doi:10.7326/M16-1110.
   PubMed Web of Science ®Google Scholar
• Redheuil A, Wu CO, Kachenoura N, et al. Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study. J Am Coll Cardiol. 2014;64(24):2619–2629. doi:10.1016/j.jacc.2014.09.060.
   PubMed Web of Science ®Google Scholar
• Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37(5):1236–1241. doi:10.1161/01.HYP.37.5.1236.
   PubMed Web of Science ®Google Scholar
• Maroules CD, Khera A, Ayers C, et al. Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study. J Cardiovasc Magn Reson. 2014;16(1):33. doi:10.1186/1532-429X-16-33.
   PubMedGoogle Scholar
• Weber T, Auer J, O’Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004;109(2):184–189. doi:10.1161/01.CIR.0000105767.94169.E3.
   PubMed Web of Science ®Google Scholar
• Willum Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006;113(5):664–670. doi:10.1161/CIRCULATIONAHA.105.579342.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336(7659):1475–1482. doi:10.1136/bmj.39609.449676.25.
   PubMed Web of Science ®Google Scholar
• Stone IS, Barnes NC, James W-Y, et al. Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med. 2016;193(7):717–726. doi:10.1164/rccm.201508-1647OC.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312.
   PubMed Web of Science ®Google Scholar
• Khanji MY, Balawon A, Boubertakh R, et al. Personalized E-coaching in cardiovascular risk reduction: a randomized controlled trial. Ann Glob Health 2019;85(1):107.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Ghezzo RH, Abboud RT, et al. Reference values of pulmonary function tests for Canadian Caucasians. Can Respir J. 2004;11(6):414–424. doi:10.1155/2004/857476.
   PubMedGoogle Scholar
• Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.doi:10.1056/NEJM198710223171717.
   PubMed Web of Science ®Google Scholar
• O'Rourke MF. Influence of ventricular ejection on the relationship between central aortic and brachial pressure pulse in man. Cardiovasc Res. 1970;4:291–300. doi:10.1093/cvr/4.3.291.
   PubMed Web of Science ®Google Scholar
• Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2(3):286–295. doi:10.1016/j.jcmg.2008.08.007.
   PubMed Web of Science ®Google Scholar
• Stone IS, John L, Petersen SE, et al. Reproducibility of arterial stiffness and wave reflections in chronic obstructive pulmonary disease: the contribution of lung hyperinflation and a comparison of techniques. Respir Med. 2013;107(11):1700–1708. doi:10.1016/j.rmed.2013.06.008.
   PubMed Web of Science ®Google Scholar
• Hickson SS, Butlin M, Broad J, et al. Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res. 2009;32(12):1079–1085. doi:10.1038/hr.2009.154.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310. doi:10.1016/S0140-6736(86)90837-8.
   PubMed Web of Science ®Google Scholar
• DeFilippis AP, Young R, Carrubba CJ, et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162(4):266–275. doi:10.7326/M14-1281.
   PubMed Web of Science ®Google Scholar
• Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61(12):1043–1047. doi:10.1136/thx.2006.064410.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31(15):1865–1871. doi:10.1093/eurheartj/ehq024.
   PubMed Web of Science ®Google Scholar
• Lee HM, Lee J, Lee K, et al. Relation between COPD severity and global cardiovascular risk in US adults. Chest 2012;142(5):1118–1125. doi:10.1378/chest.11-2421.
   PubMed Web of Science ®Google Scholar
• Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(10):948–955. doi:10.1164/rccm.200906-0876OC.
   PubMed Web of Science ®Google Scholar
• Pepin J-L, Cockcroft JR, Midwinter D, et al. Long-acting bronchodilators and arterial stiffness in patients with COPD: a comparison of fluticasone furoate/vilanterol with tiotropium. Chest 2014;146(6):1521–1530. doi:10.1378/chest.13-2859.
   PubMedGoogle Scholar
• Dransfield MT, Cockcroft JR, Townsend RR, et al. Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Respir Med. 2011;105(9):1322–1330. doi:10.1016/j.rmed.2011.05.016.
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Anderson JA, Celli B, et al. Cardiovascular events in patients with COPD: TORCH study results. Thorax 2010;65(8):719–725. doi:10.1136/thx.2010.136077.
   PubMed Web of Science ®Google Scholar
• Chen W, Thomas J, Sadatsafavi M, et al. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6.
   PubMed Web of Science ®Google Scholar
• McAllister DA, Maclay JD, Mills NL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(12):1208–1214. doi:10.1164/rccm.200707-1080OC.
   PubMed Web of Science ®Google Scholar
• Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(12):1259–1265. doi:10.1164/rccm.200701-067OC.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Dickens J, Haq I, et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013;68(7):670–676. doi:10.1136/thoraxjnl-2012-201871.
   PubMed Web of Science ®Google Scholar
• Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183(9):1129–1137. doi:10.1164/rccm.201009-1414PP.
   PubMed Web of Science ®Google Scholar
• Lilly SM, Jacobs D, Bluemke DA, et al. Resistive and pulsatile arterial hemodynamics and cardiovascular events: the multiethnic study of atherosclerosis. J Am Heart Assoc. 2014;3(6):e001223–e001223.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Pardaens K, Staessen JA, et al. The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol. 2001;38(1):227–231. doi:10.1016/S0735-1097(01)01362-6.
   PubMed Web of Science ®Google Scholar
• Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362(3):217–227. doi:10.1056/NEJMoa0808836.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010;138(1):32–38. doi:10.1378/chest.09-2810.
   PubMed Web of Science ®Google Scholar
• Grau M, Barr RG, Lima JA, et al. Percent emphysema and right ventricular structure and function: the multi-ethnic study of atherosclerosis-lung and multi-ethnic study of atherosclerosis-right ventricle studies. Chest 2013;144(1):136–144. doi:10.1378/chest.12-1779.
   PubMed Web of Science ®Google Scholar
• Schoos MM, Dalsgaard M, Kjaergaard J, et al. Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovasc Disord. 2013;13(1):84. doi:10.1186/1471-2261-13-84.
   PubMedGoogle Scholar
• Jörgensen K, Müller MF, Nel J, et al. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 2007;131(4):1050–1057. doi:10.1378/chest.06-2245.
   PubMed Web of Science ®Google Scholar
• Smith BM, Prince MR, Hoffman EA, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The multi-ethnic study of atherosclerosis COPD study. Chest 2013;144(4):1143–1151. doi:10.1378/chest.13-0183.
   PubMed Web of Science ®Google Scholar
• Ceelen F, Hunter RJ, Boubertakh R, et al. Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis. Int J Cardiovasc Imaging. 2013;29(8):1807–1817. doi:10.1007/s10554-013-0287-6.
   PubMed Web of Science ®Google Scholar
• Müllerova H, Agusti A, Erqou S, et al. Cardiovascular comorbidity in COPD: systematic literature review. Chest 2013;144(4):1163–1178. doi:10.1378/chest.12-2847.
   PubMed Web of Science ®Google Scholar
• Pocock SJ, Ariti CA, McMurray JJV, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34(19):1404–1413. doi:10.1093/eurheartj/ehs337.
   PubMed Web of Science ®Google Scholar
• Khanji MY, van Waardhuizen CN, Bicalho VVS, et al. Lifestyle advice and interventions for cardiovascular risk reduction: a systematic review of guidelines. Int J Cardiol. 2018;263:142–151. doi:10.1016/j.ijcard.2018.02.094.
   PubMed Web of Science ®Google Scholar